Wrath of the Righteous and Warhammer 40,000: Rogue Trader — together with Alcon Interactive Group revealed a selection of new ...

For almost four decades, Tom McDonald was a part of the team at Fort Worth-born Alcon, which continues to make innovative moves in the world of eyecare products. He recaps the company’s first five ...

Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.

Morgan Stanley analyst Patrick Wood lowered the firm’s price target on Alcon (ALC) to $80 from $84 and keeps an Equal Weight rating on the shares after updating the firm’s model for Q2 earnings that ...

Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access.

We recently published 10 Stocks Crash as AI Glow Fades. Alcon Inc. (NYSE:ALC) is one of Wednesday’s worst performers. Shares of Alcon Inc. snapped a six-day winning streak on Wednesday, losing 10.07 ...

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

Alcon AG (NYSE:ALC) saw its stock fall more than 2% on Thursday following a rating cut by J.P. Morgan, citing disappointing ...

The analysts cut its rating on Alcon shares to “neutral” from “overweight” and lowered its price target to SFr 62.8 for June 2027, down from SFr 94.7 for June 2026. The reduced target reflects lower ...

Alcon India unveils UNITY VCS and UNITY CS with superior efficiency for vitreoretinal and cataract surgery: Our Bureau, Bengaluru Thursday, August 21, 2025, 14:40 Hrs [IST] Alcon, ...